• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS TOTAL PSA IMMUNOASSAY; TOTAL,PROSTATE SPECIFIC ANTIGEN FOR DETECTION OF PROSTATE CANCER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS TOTAL PSA IMMUNOASSAY; TOTAL,PROSTATE SPECIFIC ANTIGEN FOR DETECTION OF PROSTATE CANCER Back to Search Results
Catalog Number ASKU
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/18/2019
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).The sample from (b)(6) 2019 was submitted for investigation.Investigations are ongoing.
 
Event Description
The initial reporter complained of discrepant results for 1 patient tested for elecsys free psa immunoassay (free psa) and elecsys total psa immunoassay (total psa) on a cobas 8000 e 602 module compared to the abbott architect method.This medwatch will cover total psa.Refer to medwatch with patient identifier (b)(6) for information on the free psa results.The initial roche results were reported outside of the laboratory where they were questioned by the doctor.There was no allegation that an adverse event occurred.The e602 module serial number was (b)(4).
 
Manufacturer Narrative
The sample from (b)(6) 2019 was sent to an external laboratory and tested by the siemens method with a total psa result of 3.15 ng/ml and a free psa result of 0.10 ng/ml.The sample from (b)(6) 2019 was tested at the investigation site on an e801 module and the customer's observation was reproduced.The sample from (b)(6) 2019 underwent interference testing where there was strong evidence for the presence of endogenous interfering substances that would considerably decrease the total psa results.Additional interference testing suggests the presence of a rare psa-isoform that cannot be completely detected by the standard total psa assay.These issues are addressed in product labeling: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design." "it is known that in rare cases psa isoforms do exist which may be measured differently by different psa tests.Findings of this kind have occasionally been reported for psa tests from various manufacturers." the investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS TOTAL PSA IMMUNOASSAY
Type of Device
TOTAL,PROSTATE SPECIFIC ANTIGEN FOR DETECTION OF PROSTATE CANCER
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key8650500
MDR Text Key146492404
Report Number1823260-2019-01997
Device Sequence Number1
Product Code MTF
Combination Product (y/n)N
PMA/PMN Number
ASKU
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 06/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 05/09/2019
Initial Date FDA Received05/29/2019
Supplement Dates Manufacturer Received05/09/2019
Supplement Dates FDA Received06/24/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age64 YR
-
-